Decitabine activates type I interferon signaling to inhibit p53-deficient myeloid malignant cells

Published: 28 May 2021| Version 1 | DOI: 10.17632/4kwg2ydz2g.1
Contributors:
Jiale Wu, Yuntong Li, Jiaqi Wu, Huaxin Song, Yigang Tang, Ni Yan, Lili Wu, Sujiang Zhang, ChunKang Chang, Min Lu

Description

Raw data of manuscript entitled "Decitabine activates type I interferon signaling to inhibit p53-deficient myeloid malignant cells"

Files

Steps to reproduce

See accompanied publication

Institutions

  • Shanghai Jiao Tong University Medical School Affiliated Ruijin Hospital
  • Shanghai Institute of Hematology

Categories

Cancer, Acute Myelogenous Leukemia, Protein P53

Licence